Antifungal Drugs Market Insights and Growth by 2031
The global antifungal drugs market is expected to grow from US$ 11,135.3 million in 2021 to US$ 13,997.4 million in 2031; it is estimated to grow at a CAGR of 3.3% from 2022 to 2031.
Antifungal drugs are used for treating common fungal infections such as fungal nail infections and vaginal infections that appear on the external surface of the body and other fungal invasive infections that occur inside the tissue of the body or in an internal organ such as the lungs and brains. It works against the fungal infection by either killing the fungal cells or constraining their growth.
The antifungal drugs market is attributed to the rising prevalence of fungal infections; increasing incidences of cancers, HIV, and hospital-acquired infections; and favorable government initiatives to combat the antifungal diseases. However, a lack of awareness regarding fungal infections is hampering the growth of the market.
The antifungal drugs market is segmented on the basis of infection type, drug type, therapeutic indication, dosage form, and geography. The report offers insights and in-depth analysis of the antifungal drugs market, emphasizing various parameters such as market trends, technological advancements, and market dynamics, as well as the competitive landscape analysis of leading market players.
Strategic Insights
Market Insights
Rising Prevalence of Fungal Infections Bolsters Antifungal Drugs Market Growth
Fungal infections are mainly caused due to microscopic fungi, which are commonly found in the atmosphere. According to the Centers for Disease Control and Prevention (CDC), in the US, from 2013 to 2017, the average incidence of fungal infection was ~9 per 100,000 people. Candidemia is among the most common bloodstream infections in the US. CDC predicts that approximately 25,000 cases of candidemia occur across the country every year. There has been significant variation in the rates of candidemia by age group. The rates have reduced considerably in infants. Candidemia rates are majorly high in people aged above 65 and older. The difference in the incidence of candidemia is due to age, race, alteration in underlying circumstances, socioeconomic status, and other factors.
Moreover, due to the tropical climate, South Asia has a high frequency of fungal infections. For instance, according to a report published by the Down To Earth organization in 2015, infection from yeast is 0.8 among 1,000 patients in the US. Moreover, the incidence is 0.2 and 0.9 per 1,000 patients in Europe and Australia, respectively. However, in India, approximately 1-12 cases occur in every 1,000 patients that are affected by the fungal infection. Therefore, the demand for antifungal drugs is increasing owing to providing treatment that helps maintain the proper immunity of the patients. Thus, the rising cases of fungal infections is likely to drive the market for antifungal drugs in the coming years.
Infection Type-Based Insights
Based on infection type, the global antifungal drugs market is bifurcated into superficial fungal infection and systemic antifungal infection. In 2021, the superficial fungal infection segment held a larger share of the market, and it is also expected to grow at the fastest rate during the forecast period. The rising prevalence of fungal infection of the skin, nails, and hair is likely to increase the growth of the antifungal drugs market during the forecast period.
Drug Type-Based Insights
Based on drug type, the global antifungal drugs market is segmented into echinocandis, azoles, polyenes, allylamines, and others. In 2021, the azoles segment held the largest share of the market. However, the polyenes segment is expected to grow at the fastest rate during the forecast period.
Therapeutic Indication-Based Insights
Based on therapeutic indication, the global antifungal drugs market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. In 2021, the candidiasis segment held the largest share of the market. However, the dermatophytosis segment is expected to grow at the fastest rate during the coming years.
Dosage Form-Based Insights
based on dosage form, the global antifungal drugs market is segmented into drugs, ointment, powder, and others. In 2021, the drugs segment held the largest share of the market, and it is expected to grow at the fastest rate during the coming years.
The Asia Pacific antifungal drugs market is expected to grow at the fastest rate during the forecast period. The market is estimated to grow during the forecast period due to the growing pharmaceutical industry in the countries such as China, Japan, and India. China's pharmaceutical industry is among the largest pharmaceutical industry across the globe. The country has shown significant growth in active pharmaceutical ingredient manufacturing, competitiveness, innovations, and final dosage formation. Hence, most multinational companies are showing interest in the Chinese market for drug sales.
In 2021, North America held the largest share of the antifungal drugs market. The North America antifungal drugs market is studied based on the three major countries—the US, Canada, and Mexico. The market growth in the region is majorly contributed by rising cases of fungal infections across the countries and growing awareness programs such as ‘Fungal Disease Awareness Week’. In addition, Mexico is expected to offer several growth opportunities in the coming years due to the rising prevalence of fungal diseases. For instance, according to an article published in the Brazilian Journal of Infectious Diseases in 2021, states that invasive fungal infections affect more than 1.5 million people per year in Mexico.
By geography, the antifungal drugs market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Merck And Co., Inc.
- Scynexis Inc.
- Novartis International AG
- Abbott Laboratories
- Bayer AG
- Glenmark Pharmaceutical
- Glaxosmithkline Plc.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Infection Type, Drug Type, Therapeutic Indication, and Dosage Form
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antifungal Drugs Market – By Infection Type
1.3.2 Global Antifungal Drugs Market – By Drug Type
1.3.3 Global Antifungal Drugs Market – By Therapeutic Indication
1.3.4 Global Antifungal Drugs Market – By Dosage Form
1.3.5 Global Antifungal Drugs Market – By Geography
2. Global Antifungal Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antifungal Drugs– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinion
5. Global Antifungal Drugs Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Fungal Infections
5.1.2 Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections
5.1.3 Favourable Government Initiatives to Combat the Antifungal Diseases
5.2 Key Market Restraints
5.2.1 Lack of Awareness Regarding Fungal Infections
5.3 Key Market Opportunities
5.3.1 Growing Pharmaceutical Industry in Developing Regions
5.4 Future Trends
5.4.1 Public-Private Partnerships Agreements in the Pharmaceutical Market
5.5 Impact Analysis of Drivers and Restraints
6. Antifungal Drugs Market – Global Analysis
6.1 Global Antifungal Drugs Market Revenue Forecasts And Analysis
6.2 Global Antifungal Drugs Market, By Geography - Forecasts And Analysis
6.3 Performance Of Key Players
6.4 Positioning Of Key Players
7. Antifungal Drugs Market Analysis And Forecasts To 2027 Infection Type
7.1 Overview
7.2 Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)
7.3 Superficial Fungal Infection
7.3.1 Overview
7.3.2 Superficial Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Systemic Fungal Infection
7.4.1 Overview
7.4.2 Systemic Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)
8. Antifungal Drugs Market Analysis And Forecasts To 2027 Drug Type
8.1 Overview
8.2 Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)
8.3 Echinocandins
8.3.1 Overview
8.3.2 Echinocandins Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Azoles
8.4.1 Overview
8.4.2 Azoles Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Polyenes
8.5.1 Overview
8.5.2 Polyenes Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Allylamines
8.6.1 Overview
8.6.2 Allylamines Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
9. Antifungal Drugs Market Analysis And Forecasts To 2027 – Therapeutic Indication
9.1 Overview
9.2 Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)
9.3 Aspergillosis
9.3.1 Overview
9.3.2 Aspergillosis Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Dermatophytosis
9.4.1 Overview
9.4.2 Dermatophytosis Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Candidiasis
9.5.1 Overview
9.5.2 Candidiasis Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
10. Antifungal Drugs Market Analysis And Forecasts To 2027 Dosage Form
10.1 Overview
10.2 Global Antifungal Drugs Market Share by Dosage Form 2018 & 2027 (%)
10.3 Drugs
10.3.1 Overview
10.3.2 Drugs Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Ointment
10.4.1 Overview
10.4.2 Ointment Market Revenue and Forecast to 2027 (US$ Mn)
10.5 Powder
10.5.1 Overview
10.5.2 Powder Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
11. Antifungal Drugs Market Revenue And Forecasts To 2027 Regional Analysis
11.1 North America Antifungal drugs Market
11.1.1 Overview
11.1.2 North America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.1.3 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.4 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.5 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.6 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.1.7 North America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.1.8 US Antifungal Drugs Market
11.1.8.1 US Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.8.3 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.8.4 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.8.5 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.1.9 Canada Antifungal Drugs Market
11.1.9.1 Canada Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.9.3 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.9.4 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.9.5 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.1.10 Mexico Antifungal Drugs Market
11.1.10.1........ Mexico Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.10.2. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.10.3. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.10.4. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.10.5. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2 Europe Antifungal Drugs Market
11.2.1 Overview
11.2.2 Europe Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.2.3 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.4 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.5 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.6 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.7 Europe Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.2.8 UK Antifungal Drugs Market
11.2.8.1 UK Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.8.3 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.8.4 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.8.5 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.9 Germany Antifungal Drugs Market
11.2.9.1 Germany Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.9.3 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.9.4 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.9.5 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.10 France Antifungal Drugs Market
11.2.10.1........ France Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.10.3. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.10.4. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.10.5. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.11 Spain Antifungal Drugs Market
11.2.11.1. Spain Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.11.3... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.11.4... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.11.5... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.12 Italy Antifungal Drugs Market
11.2.12.1.. Italy Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.12.2..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.12.3..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.12.4..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.12.5..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3 Asia Pacific Antifungal Drugs Market
11.3.1 Overview
11.3.2 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.3.3 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.4 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.5 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.6 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.7 Asia Pacific Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.3.8 China Antifungal Drugs Market
11.3.8.1 China Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.8.3 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.8.4 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.8.5 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.9 Japan Antifungal Drugs Market
11.3.9.1 Japan Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.9.3 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.9.4 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.9.5 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.10 India Antifungal Drugs Market
11.3.10.1.. India Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.10.3.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.10.4.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.10.5.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.11 Australia Antifungal Drugs Market
11.3.11.1..... Australia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.11.3... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.11.4... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.11.5... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.12 South Korea Antifungal Drugs Market
11.3.12.1........ South Korea Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12.2....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.12.3....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.12.4....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.12.5....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4 Middle East & Africa Antifungal Drugs Market
11.4.1 Overview
11.4.2 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.4.3 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.4 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.5 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.6 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4.7 Middle East & Africa Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.4.8 UAE Antifungal Drugs Market
11.4.8.1 UAE Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.8.3 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.8.4 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.8.5 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4.9 Saudi Arabia Antifungal Drugs Market
11.4.9.1 Saudi Arabia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.9.3 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.9.4 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.9.5 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4.10 South Africa Antifungal Drugs Market
11.4.10.1........ South Africa Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.2....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.10.3....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.10.4....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.10.5....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.5 South and Central America Antifungal Drugs Market
11.5.1 Overview
11.5.2 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.5.3 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.5.4 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.5.5 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.5.6 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.5.7 South and Central America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.5.8 Brazil Antifungal Drugs Market
11.5.8.1 Brazil Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.2 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.5.8.3 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.5.8.4 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.5.8.5 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.5.9 Argentina Antifungal Drugs Market
11.5.9.1 Argentina Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.9.2 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.5.9.3 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.5.9.4 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.5.9.5 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
12. Antifungal Drugs Market– Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies Done By The Companies In The Market, (%)
12.4 Recent Development Done By The Companies In The Market (2016-2019)
13. Antifungal Drugs Market–Key Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 NOVARTIS AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck & Co., Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GlaxoSmithKline plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.6 BAYER AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 SANOFI S.A
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product portfolio
13.7.5 SWOT ANALYSIS
13.7.6 KEY DEVELOPMENTS
13.8 GILEAD SCIENCES, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SCYNEXIS, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Glenmark Pharmaceuticals
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Country Estimated Burden of Candidaemia
Table 2. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 3. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 4. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 5. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 6. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 7. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 8. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 9. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 10. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 11. Canada Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 12. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 13. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 14. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 15. Mexico Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 16. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 17. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 18. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 19. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 20. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 21. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 22. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 23. UK Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 24. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 25. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 26. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 27. Germany Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 28. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 29. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 30. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 31. France Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 32. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 33. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 34. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 35. Spain Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 36. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 37. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 38. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 39. Italy Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 40. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 41. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 42. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 43. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 44. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 45. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 46. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 47. China Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 48. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 49. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 50. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 51. Japan Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 52. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 53. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 54. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 55. India Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 56. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 57. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 58. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 59. Australia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 60. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 61. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 62. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 63. South Korea Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 64. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 65. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 66. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 67. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 68. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 69. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 70. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 71. UAE Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 72. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 73. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 74. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 75. Saudi Arabia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 76. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 77. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 78. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 79. South Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 80. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 81. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 82. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 83. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 84. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 85. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 86. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 87. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 88. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 89. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 90. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 91. Argentina Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 92. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 93. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 94. Recent Development Done By The Companies In The Market
Table 95. Glossary of Terms, Antifungal Drugs Market
LIST OF FIGURES
Figure 1. Antifungal Drugs Market Segmentation
Figure 2. Antifungal drugs Segmentation, By Region
Figure 3. Asia Pacific Antifungal Drugs Market, Revenue (US$ Mn), 2018 & 2027
Figure 4. Global Antifungal Drugs Market By Infection Type, Market Share (%), 2018
Figure 5. Global Antifungal Drugs Market By Drug Type, Market Share (%), 2018
Figure 6. Global Antifungal Drugs Market By Therapeutic Indication, Market Share (%), 2018
Figure 7. Global Antifungal Drugs Market By Dosage Form, Market Share (%), 2018
Figure 8. North America PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Asia pacific PEST Analysis
Figure 11. Middle East and Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Antifungal Drugs Market Impact Analysis of Drivers and Restraints
Figure 14. Global Antifungal Drugs Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 15. Global Antifungal Drugs Market – By Geography Forecasts And Analysis – 2018- 2027
Figure 16. Market Positioning Of Key Player In Global Antifungal Drugs Market
Figure 17. Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)
Figure 18. Superficial Fungal Infection Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Systemic Fungal Infection Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)
Figure 21. Echinocandins Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Azoles Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Polyenes Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Allylamins Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)
Figure 27. Aspergillosis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Dermatophytosis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Candidiasis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 30. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Global Antifungal drugs Market Share by Dosage Form 2018 & 2027 (%)
Figure 32. Dugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. Ointment Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 34. Powder Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 35. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 36. North America Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 37. North America Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 38. North America Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
Figure 39. US Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 40. Canada Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 41. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 42. Europe Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 43. Europe Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 44. Europe Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
Figure 45. UK Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 46. Germany Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 47. France Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 48. Spain Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 49. Italy Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 50. Asia Pacific Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 51. Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 52. Asia Pacific Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
Figure 53. China Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 54. Japan Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 55. India Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 56. Australia Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 57. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 58. Middle East & Africa Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 59. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 60. Middle East & Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
Figure 61. UAE Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 62. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 63. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 64. South And Central America Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 65. South And Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 66. South and Central America Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
Figure 67. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 68. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 69. Comparative Company Analysis
Figure 70. Growth Strategies Done By The Companies In The Market, (%)
The List of Companies
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Merck And Co., Inc.
- Scynexis Inc.
- Novartis International AG
- Abbott Laboratories
- Bayer AG
- Glenmark Pharmaceutical
- Glaxosmithkline Plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For